Pacira BioSciences, Inc. (PCRX)
Nasdaq: PCRX · Pharmaceutical Preparations · Brisbane, CA · filing with the SEC since 2007
Grade6.3
◀ Past 8.0● Present 6.1▶ Future 4.9
Filings
325 filings since 2017 beside 490 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 29, 2025.
Filings a yearinsider forms included
727987801057374111
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Jun 11, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 8, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jun 30, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jun 28, 2026
Jun 11, 2026
8-K items 5.02, 5.07, 8.01, 9.01
Officer or director change; Shareholder vote; Other event · Current report
Jun 9, 2026
40 of 325 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.